May 19, 2016
PMO Interview with the Innovator Series: Volume 4Video Categories: PMO Interview with the Innovator Series
July 17, 2018
Explaining Treatment Regimens to Patients with HR+/HER2â€“Metastatic Breast Cancer
Dr Thomas Bachelot is careful to set reasonable expectations for his patients with HR+/HER2â€“metastatic breast cancer regarding how long their treatment will last and how it will impact them.
September 20, 2013
The Value of Personalized Medicine
John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later